Because the overexpression of NEUROD1 has been linked to the development of metastases and aggressive SCLC phenotypes [68], it has been suggested that N-Myc activation results in the variant characteristics via NEUROD1 signal activation. The gene discussed is MYCN; the disease is small cell lung carcinoma.